RSS Feeds
Search

Articles

Pharmalicensing brings you advice, commentary and analysis from industry experts.

Articles

No results found for given criteria.
Please try to put more general criteria into your selection.

Related Reports

Market Research Reports provided by reports.iptechex.com
Vertex’s VX770 Is Poised To Become The First Targeted Therapy To Be Approved In Cystic Fibrosis
Mar 2011 - 4 pages - $500
Liver Fibrosis Global Clinical Trials Review, Q1, 2011
Apr 2011 - 57 pages - $1,000
Liver Fibrosis Global Clinical Trials Review, H2, 2011
Sep 2011 - 83 pages - $1,000
Apotex Inc.: PharmaVitae Profile
Dec 2010 - 37 pages - $5,700
Liver Fibrosis - Pipeline Review, Q4 2010
Dec 2010 - 29 pages - $500
Nicotine Dependence Market Forecast
Mar 2009 - $15,200
Cystic Fibrosis – Pipeline Assessment and Market Forecasts to 2017
Aug 2010 - 49 pages - $2,000
F. Hoffmann-La Roche Ltd: PharmaVitae Report
Jun 2011 - 94 pages - $5,700
H. Lundbeck A/S: PharmaVitae Profile
Dec 2010 - 58 pages - $5,700
Worldwide Market for Rheumatoid Arthritis and Lupus Treatments (Autoimmune Disease Markets)
Jan 2008 - 180 pages - $3,500
More Related Market Research Reports >>>

Your selection

Industry sector
Pharmaceutical del
Prescription del
Therapeutic target
Hospital and Surgery del
Fibrosis del
Year
2006 del

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us